Tuberous sclerosis complex: a brave new world?

Area of Science:

• Genetics
• Molecular Biology
• Neurology

Background:

• Tuberous sclerosis complex (TSC) is a genetic disorder affecting multiple organs.
• Mutations in TSC1 or TSC2 genes cause TSC, leading to severe neurological issues like epilepsy, developmental delay, and autism.

Purpose of the Study:

• To review recent advances in TSC research, particularly focusing on the TSC1/TSC2 genes and their role in mTORC1 signaling.
• To discuss new animal models, translational data, and clinical trials involving mTORC1 inhibitors.

Main Methods:

• Review of basic science findings on TSC1/TSC2 gene function.
• Analysis of new animal models for TSC.
• Examination of translational data and clinical trials for mTORC1 inhibitors.

Main Results:

• TSC1 and TSC2 genes are identified as key regulators of the mammalian target of rapamycin (mTOR) kinase within mTOR complex 1 (mTORC1).
• Development of novel animal models and translational data supporting mTORC1 as a therapeutic target.
• Clinical trials investigating mTORC1 inhibitors like rapamycin show potential.

Conclusions:

• Recent breakthroughs have revitalized TSC research and offer new therapeutic avenues.
• While the impact of mTORC1 inhibitors on TSC patient care is still under evaluation, molecular medicine shows great promise for treating this complex genetic disorder.